Principles and Practice of Nutritional Support for Surgical Patients

  • Maheswari Senthil
  • Bobby Rupani
  • Jondavid H. Jabush
  • Edwin A. Deitch


You are asked to consult on a 75-year-old former school teacher who is in the intensive care unit for nutritional support. Since being admitted to the hospital 9 days ago, the patient has had a protracted hospital course and has had no nutritional support. The patient is receiving mechanical ventilation and is receiving antimicrobial therapy for a ventilatorassociated pneumonia. She is septic and has necessitated pressor support in order to achieve hemodynamic goals. The patient now has a dedicated central line for parenteral nutrition. A feeding jejunostomy was placed several days ago.Which of the following is the most appropriate route for nutritional support for this patient?
  1. (A)

    Central venous

  2. (B)


  3. (C)

    Peripheral venous

  4. (D)


  5. (E)

    Do not initiate any nutritional support



Intensive Care Unit Patient Enteral Nutrition Total Parenteral Nutrition Nutritional Support Enteral Feeding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Long CL. Metabolic response to injury and illness: estimation of energy and protein needs from indirect calorimetry and nitrogen balance. J Parenter Enteral Nutr 1979; 3:452–456.CrossRefGoogle Scholar
  2. 2.
    Hill AG, Hill GL. Metabolic response to severe injury. Br J Surg 1998; 85:884–890.CrossRefPubMedGoogle Scholar
  3. 3.
    Bessey PQ, Watters JM, Aoke TT, et al. Combined hormonal infusion stimulates the metabolic response to injury. Ann Surg 1984; 200:264–281.CrossRefPubMedGoogle Scholar
  4. 4.
    Aulick LH, Wroczyski FA, Coil JA, et al. Metabolic and thermoregulatory responses to burn wound colonization. J Trauma 1989; 29:478–483.CrossRefPubMedGoogle Scholar
  5. 5.
    Deitch EA. Bacterial translocation of the gut flora. J Trauma 1990; 30:S184–S190.CrossRefPubMedGoogle Scholar
  6. 6.
    Deitch EA. Multiple organ failure: pathophysiology and potential future therapies. Ann Surg 1992; 216:117–134.CrossRefPubMedGoogle Scholar
  7. 7.
    Deitch EA, Xu DZ, Franko L, et al. Evidence favoring the role of the gut as a cytokine generating organ in rats subjected to hemorrhagic shock. Shock 1994; 1:141–146.PubMedGoogle Scholar
  8. 8.
    Deitch EA. Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 2001; 7:92–98.CrossRefPubMedGoogle Scholar
  9. 9.
    Mainous MR, Block EF, Deitch EA. Nutritional support of the gut: how and why. New Horiz 1994; 2:193–201.PubMedGoogle Scholar
  10. 10.
    Hulsewe KWE, van Acker BAC, von Meyenfield MF, et al. Nutritional depletion and dietary manipulation: effects on the immune response. World J Surg 1999; 23:536–544.CrossRefPubMedGoogle Scholar
  11. 11.
    Deitch EA. Infection in the compromised host. Surg Clin North Am 1988; 68:181–197.PubMedGoogle Scholar
  12. 12.
    Alexander JW, MacMillan BG, Stinnett JD, et al. Beneficial effects of aggressive feeding in severely burned children. Ann Surg 1980; 192:505–517.CrossRefPubMedGoogle Scholar
  13. 13.
    Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications: the results of a meta-analysis. Ann Surg 1992; 216:172–183.CrossRefPubMedGoogle Scholar
  14. 14.
    Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27:2799–2805.CrossRefPubMedGoogle Scholar
  15. 15.
    Jeejeebhoy KN. How should we monitor nutritional support: structure or function? New Horiz 1994; 2:131–138.PubMedGoogle Scholar
  16. 16.
    Burke JF, Wolfe RR, Mullany CS, et al. Glucose requirements following burn injury. Ann Surg 1979; 190:274–285.CrossRefPubMedGoogle Scholar
  17. 17.
    Van Den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359–1367.CrossRefPubMedGoogle Scholar
  18. 18.
    Greig PD, Elwyn DH, Askanazi J, et al. Parenteral nutrition in septic patients: effect of increasing nitrogen intake. Am J Clin Nutr 1987; 46:1040–1047.PubMedGoogle Scholar
  19. 19.
    Endres S, Ghorbani R, Kelly VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265–271.PubMedCrossRefGoogle Scholar
  20. 20.
    Nghia MV, Waycaster M, Acuff RV, et al. Effects of postoperative carbohydrate overfeeding. Am Surg 1987; 53:632–635.Google Scholar
  21. 21.
    Campbell SM, Kudsk KA. “High tech” metabolic measurements: useful in daily clinical practice? J Parenter Enteral Nutr 1983; 12:610–612.CrossRefGoogle Scholar
  22. 22.
    Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of the published data and recommendations for future research directions. J Parenter Enteral Nutr 1977; 21:133–156.CrossRefGoogle Scholar
  23. 23.
    Harris J, Benedict F. A Biometric Study of Basal Metabolism in Man. Washington, DC: Carnegie Institute, 1919.Google Scholar
  24. 24.
    Weissman C, Kemper M, Askanazi J, et al. Resting metabolic rate of the critically ill patient: measured versus predicted. J Anesthesiol 1986; 64:673–679.CrossRefGoogle Scholar
  25. 25.
    Wilmore DW, Mason AD Jr, Johnson DW, et al. Effect of ambient temperature on heat production and heat loss in burn patients. J Appl Physiol 1975; 38:593–597.PubMedGoogle Scholar
  26. 26.
    Saito H, Trocki O, Alexander JW, et al. The effect of route of nutrient administration on the nutritional state, catabolic hormone secretion and gut mucosal integrity after burn injury. J Parenter Enteral Nutr 1987; 11:1–7.CrossRefGoogle Scholar
  27. 27.
    McDonald WS, Sharpe CW Jr, Deitch EA. Immediate enteral feeding in burn patients is safe and effective. Ann Surg 1991; 213:177–183.CrossRefPubMedGoogle Scholar
  28. 28.
    McGeer AJ, Detsky AS, O’Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: a metaanalysis. Nutrition 1990; 6:233–2340.PubMedGoogle Scholar
  29. 29.
    The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group: Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991; 325:525–532.CrossRefGoogle Scholar
  30. 30.
    Herndon DN, Barrow RE, Stein M, et al. Increased mortality with intravenous supplemented feeding in severely burned patients. J Burn Care Rehabil 1989; 10:309–313.CrossRefPubMedGoogle Scholar
  31. 31.
    Mochizuki H, Trocki O, Dominioni L, et al. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding. Ann Surg 1984; 200:297–310.CrossRefPubMedGoogle Scholar
  32. 32.
    Deitch EA, Sambol JT. The gut-origin hypothesis of MODS. In Deitch EA, Vincent JL, Windsor A, eds. Sepsis and Multiple Organ Dysfunction. Philadelphia: WB Saunders, 2002: 105–116.Google Scholar
  33. 33.
    Meyer J, Yurt RW, Duhaney R, et al. Differential neutrophil activation before and after endotoxin infusion in enterally versus parenterally fed human volunteers. Surg Gynecol Obstet 1988; 167:501–509.PubMedGoogle Scholar
  34. 34.
    Fong Y, Marano MA, Barber A, et al. Total parenteral nutrition and bowel rest modify the response to endotoxin in humans. Ann Surg 1989; 210:449–456.CrossRefPubMedGoogle Scholar
  35. 35.
    Wilmore DW, Smith RJ, O’Dwyer ST, et al. The gut: a central organ after surgical stress. Surgery 1988; 104:917–923.PubMedGoogle Scholar
  36. 36.
    Speath G, Berg RD, Specian RD, Deitch EA. Food without fiber promotes bacterial translocation from the gut. Surgery 1990; 108:240–247.Google Scholar
  37. 37.
    Alverdy JC, Aoys E, Moss GS. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 1988; 104:186–190.Google Scholar
  38. 38.
    Heyland DK, Novak, F, Drover, J et al. Should immunonutrition become routine in critically ill patients?: a systematic review of evidence. JAMA 2001; 286:944–953.CrossRefPubMedGoogle Scholar
  39. 39.
    Galban C, Montejo JC, Mesejo A, et al. An immune enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000; 28:643–648.CrossRefPubMedGoogle Scholar
  40. 40.
    Kompan L, Kremzar B, Gadzijev E, et al. Effects of early enteral nutrition on intestinal permeability and the development of multiple organ failure after multiple injury. Intensive Care Med 1999; 25:157–161.CrossRefPubMedGoogle Scholar
  41. 41.
    Zaloga GP, Roberts PR, Marik P. Feeding the hemodynamically unstable patient: a critical evaluation of the evidence. Nutr Clin Pract 2003; 18:285–293.CrossRefPubMedGoogle Scholar
  42. 42.
    McClave SA, Chang WK. Feeding the hypotensive patient: does enteral feeding precipitate or protect against ischemic bowel? Nutr Clin Pract 2003; 18:279–284.CrossRefPubMedGoogle Scholar
  43. 43.
    Sarr MG. Appropriate use, complications and advantages demonstrated in 500 consecutive needle catheter jejunostomies. Br J Surg 1999; 86:557–561.CrossRefPubMedGoogle Scholar
  44. 44.
    Tapia J, Murguia R, Garcia G, et al. Jejunostomy techniques, indications and complications. World J Surg 1999; 23:596–602.CrossRefPubMedGoogle Scholar
  45. 45.
    American Gastroenterological Association Medical Position Statement: guidelines for the use of enteral nutrition. Gastroenterology 1995; 108:1280–1301.CrossRefGoogle Scholar
  46. 46.
    Gilpin DA, Barrow RE, Rutan RL, et al. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994; 220:19–24.CrossRefPubMedGoogle Scholar
  47. 47.
    Cioffi WG, Gore DC, Rue LW, et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 1994; 220:310–316.CrossRefPubMedGoogle Scholar
  48. 48.
    Wilmore DW. The use of growth hormone in severely ill patients. Adv Surg 1999; 33:261–274.PubMedGoogle Scholar
  49. 49.
    Gibson FAM, Hinds CJ. Growth hormone and insulin-like growth factors in critical illness. Intensive Care Med 1997; 23:369–378.CrossRefPubMedGoogle Scholar
  50. 50.
    Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone in critically ill adults. N Engl J Med 1999; 341:785–792.CrossRefPubMedGoogle Scholar
  51. 51.
    Haskel Y, Xu D, Lu Q, et al. Elemental diet-induced bacterial translocation can be hormonally modulated. Ann Surg 1993; 217:634–642.CrossRefPubMedGoogle Scholar
  52. 52.
    Evers BM, Izukura M, Townsend CM, et al. Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet. Dig Dis Sci 1992; 37:426–431.CrossRefPubMedGoogle Scholar
  53. 53.
    Jacobs DO, Evans DA, Mealy K, et al. Combined effects of glutamine and epidermal growth factor on the rat intestine. Surgery 1988; 104:358–364.PubMedGoogle Scholar
  54. 54.
    Gianotti L, Alexander JW, Fukishima R, et al. Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate. Am J Surg 1993; 165:195–200.CrossRefPubMedGoogle Scholar
  55. 55.
    Barquist E, Kirton O, Windsor J, et al. The impact of antioxidant and splanchnic-directed therapy on persistent uncorrected gastric mucosal pH in the critically injured trauma patient. J Trauma 1998; 44:355–360.CrossRefPubMedGoogle Scholar
  56. 56.
    Porter JM, Ivatoury RR, Azimuddin K, et al. Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study. Am Surg 1999; 65:478–483.PubMedGoogle Scholar
  57. 57.
    Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236:814–822.CrossRefPubMedGoogle Scholar
  58. 58.
    Demling RH, Debiasse MA. Micronutrients in critical illness. Crit Care Clin 1995; 11:651–673.PubMedGoogle Scholar
  59. 59.
    Rotruck J, Pope A, Ganther H, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 1979; 179:588–590.CrossRefGoogle Scholar
  60. 60.
    Haeker F, Stewart P. Effects of acute illness on selenium homeostasis. Crit Care Med 1990; 18:442–449.CrossRefGoogle Scholar
  61. 61.
    McKenzie RL, Rea HM, Thomson CD, et al. Selenium concentration and glutathione peroxidase activity in blood of New Zealand infants and children. Am J Clin Nutr 1978; 31:1413–1418.PubMedGoogle Scholar
  62. 62.
    Levine RJ, Olson RE. Blood selenium in Thai children with protein calorie malnutrition. Proc Soc Exp Biol Med 1970; 134:1030.PubMedGoogle Scholar
  63. 63.
    Fleming CR, Lie JT, Mc Call JT, et al. Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterology 1982; 83:689–693.PubMedGoogle Scholar
  64. 64.
    Brown MR, Cohen HJ, Lyons JM, et al. Proximal muscle weakness and selenium deficiency associated with long term parenteral nutrition. Am J Clin Nutr 1986; 43:549–554.PubMedGoogle Scholar
  65. 65.
    Anderson RA, Polansky MM, Bryden NA, et al. Supplemental-chromium effects on glucose, insulin, glucagon and urinary chromium losses in subjects consuming controlled low chromium diets. Am J Clin Nutr 1991; 54:909–916.PubMedGoogle Scholar
  66. 66.
    Brown RO, Forloines-Lynn S, Cross RE, et al. Chromium deficiency after long term parenteral nutrition. Dig Dis Sci 1986; 31:661–664.CrossRefPubMedGoogle Scholar
  67. 67.
    Kohn S, Kohn D, Schiller D. Effect of zinc supplementation on epidermal Langerhans cells of elderly patients with decubitus ulcers. J Dermatol 2000; 27:258–263.PubMedGoogle Scholar
  68. 68.
    Rostan EF, DeBuys HV, Madey DL, et al. Evidence supporting zinc as an antioxidant for skin. Int J Dermatol 2002; 41:606–611.CrossRefPubMedGoogle Scholar
  69. 69.
    Bogden JD. Influence of zinc on immunity in the elderly. J Nutr Health Aging 2004; 8:48–54.PubMedGoogle Scholar
  70. 70.
    Deitch EA, Sittig KM. A serial study of the erythropoietic response to thermal injury. Ann Surg 1993; 217:293–299.CrossRefPubMedGoogle Scholar
  71. 71.
    Weinberg ED. Iron depletion: a defense against intracellular infection and neoplasia. Life Sci 1992; 50:1289–1297.CrossRefPubMedGoogle Scholar
  72. 72.
    Demling RH, Desanti L. Oxandralone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 1997; 43:47–51.CrossRefPubMedGoogle Scholar
  73. 73.
    Wolf SE, Thomas SJ, Dasu MR, et al. Improved net protein balance, lean mass and gene expression changes with oxandralone treatment in the severly burned. Ann Surg 2003; 237:801–811.CrossRefPubMedGoogle Scholar
  74. 74.
    Mendenhall CL, Moritz TE, Roselli GA, et al. A study of oral nutritional support with oxandralone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993; 17:564–570.CrossRefPubMedGoogle Scholar
  75. 75.
    Berger J, Poll L, Hall C, et al. Oxandralone in AIDS wasting myopathy. AIDS 1996; 10:1657–1662.PubMedGoogle Scholar
  76. 76.
    Thomas S, Wolf SE, Murphy KD, et al. The long term effect of oxandralone on hepatic acute phase proteins in severely burned children. J Trauma 2003; 56:37–44.CrossRefGoogle Scholar
  77. 77.
    Demling RH. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandralone, after severe burn injury. Burns 1999; 25:215–221.CrossRefPubMedGoogle Scholar
  78. 78.
    Fox M, Minor A, et al. Oxandralone: a potent anabolic steroid. J Clin Endocrinol Metab 1962; 22:921–923.CrossRefPubMedGoogle Scholar
  79. 79.
    Karim A, Ranney RE, Zagarella BA, et al. Oxandralone disposition and metabolism in man. Clin Pharmacol Ther 1973; 14:862–866.PubMedGoogle Scholar
  80. 80.
    Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 1995; 222:283–297.CrossRefPubMedGoogle Scholar
  81. 81.
    Ferrando AA, Chinkes DL, Wolf SE, et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999; 229:11–18.CrossRefPubMedGoogle Scholar
  82. 82.
    Thomas SJ, Morimato K, Herndon DN, et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002; 132:341–347.CrossRefPubMedGoogle Scholar
  83. 83.
    Herndon DN, Hart DW, Steven EW, et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001; 345:1223–1229.CrossRefPubMedGoogle Scholar
  84. 84.
    Hart DW, Wolf SE, Chinkes DL, et al. B-blockade and growth hormone after burn. Ann Surg 2002; 236:450–457.CrossRefPubMedGoogle Scholar
  85. 85.
    Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high risk patients undergoing vascular surgery. N Engl J Med 1999; 341:1789–1794.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Maheswari Senthil
    • 1
    • 2
    • 3
  • Bobby Rupani
    • 1
    • 2
    • 3
  • Jondavid H. Jabush
    • 1
    • 2
    • 3
  • Edwin A. Deitch
    • 1
    • 2
    • 3
  1. 1.Department of SurgeryUniversity of Medicine and Dentistry of New JerseyUSA
  2. 2.New Jersey Medical SchoolUniversity of Medicine and Dentistry of New JerseyUSA
  3. 3.University HospitalNewarkUSA

Personalised recommendations